The aim of this thread is to hear more about our ICN members!
Instructions: Please post a comment in this thread telling us your name, location and the discipline(s) you are currently working in. We would also like to hear your answer to one or more of the following questions:
1. What N-of-1 and single-case projects are you working on right now?
2. What excites you most about the field of N-of-1 trials and single-case designs?
3. Why did you join the ICN?
Please aim for 250 words or less
Hello!
I am Brad Bloomfield, and I am a lecturer in Applied Behaviour Analysis (ABA) at Monash University and I’m based in Melbourne, Australia.
1. What N-of-1 and single-case projects are you working on right now?
I’m interested in the use of telehealth to support families and schools gain skills in behaviour support strategies. I am currently working on a teacher training study on classroom management strategies and parent training in paediatric feeding intervention study.
2. What excites you most about the field of N-of-1 trials and single-case designs?
I really like how direct the impact of the intervention can show changes in observed behaviour in a socially significant way. There is a lot of flexibility within these designs that support individualised systems of supports.
3. Why did you join the ICN?
I enjoy using single case research design in my program of research and also teach this to the students in the course I teach. I am really interested to expand my understanding of single-case research outside the field of ABA and build connections with other scholars and practitioners in the field.
Hello!
My name is Shamima Banu and I am currently studying medicine at The University of Queensland in Brisbane, Australia.
1. What N-of-1 and single-case projects are you working on right now?
My exposure to N-of-1 studies was made possible by Dr Nikles and Dr McDonald since 2018. I have been working on N-of-1 studies relating to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and other systematic reviews involving N-of-1 studies.
2. What excites you most about the field of N-of-1 trials and single-case designs?
The translational capacity of this field into clinical medicine, especially personalised medicine to individual patients is what that excites me the most on working in the field.
3. Why did you join the ICN?
I decided to join the ICN to expand my involvement and knowledge on the field of N-of-1 trials and single-case designs. I hope to learn more about this methodology and it's use in clinical medicine.
Greetings! I'm Eric J. Daza, a digital health data scientist at Evidation Health based out of the San Francisco Bay Area, CA, USA. 1. What N-of-1 and single-case projects are you working on right now? Stats-of-1! It's a blog for per-individual study design and analysis methods, that is lay-oriented and interdisciplinary. Our mission is to facilitate cross-disciplinary collaboration that will enhance idiographic data collection and analysis procedures across health disciplines. We call this statistical field esametry.
2. What excites you most about the field of N-of-1 trials and single-case designs?
The sheer potential for n-of-1/single-case methods to innovate and advance digital health applications, and vice-versa.
3. Why did you join the ICN? I was graciously invited by Drs. Nikles and McDonald to join sometime in 2016-2017. Very grateful they reached out to me! The ICN is a great resource for building community around our common interests.
Hi!
My name is Rachael Dodds and I am currently studying medicine at the University of Queensland in Brisbane, Australia.
1. What N-of-1 and single-case projects are you working on right now?
I was introduced to N-of-1 projects when I completed some volunteer research last year. I'm not currently working on any N-of-1 projects.
2. What excites you most about the field of N-of-1 trials and single-case designs?
How widely applicable they are, especially in medicine and healthcare!
3. Why did you join the ICN?
I decided to join the ICN as I've become interested in N-of-1 projects and wanted to be more involved in spreading awareness about these trials in addition to learning more about the field.
Hi!
My name is Patrick Onghena, and I am currently working at the Faculty of Psychology and Educational Sciences, KU Leuven, Belgium.
1. What N-of-1 and single-case projects are you working on right now?
I'm involved in several applied and methodological single-case projects. The applied projects include a personalized intensive exposure-based intervention targeting persistent anxiety and (imminent) school absenteeism in youth and a project on behavioral parent training for children with attention-deficit/hyperactivity disorder. The major methodological projects are software development for comprehensive single case data analysis and the development of mixed methods single case research.
2. What excites you most about the field of N-of-1 trials and single-case designs?
I was trained as a clinical psychologist and psychotherapist and it always struck me how much can be learned about "human nature" (and its diversity) by intensively talking, listening, and working with an individual person. Psychotherapy is in a way a discovery of personal patterns, recurrences, and individual laws of behaviors, thoughts, words, and feelings, before trying to incite changes. So when I started with my PhD research about the effectiveness of psychotherapy more than 30 years ago, I really wanted to keep that focus on the individual. SCEDs seemed the ideal method to evaluate effectiveness and keep that focus, and I still think it is. After 30 years, it still excites me to explain to my colleagues the painfully obvious that a between-subjects effect is fundamentally different from a within-subject effect. It is fundamentally different for the science of psychology and it is fundamentally different for the person (and his family and friends) who is experiencing the effect.
3. Why did you join the ICN?
I think there is a need for more community building around N-of-1 and SCEDs. N-of-1 and SCED researchers are still a very small minority. And minorities need support. Even if one is a single-case researcher, it shouldn't imply that one is a lonely researcher.
Hi!
I am Cheuk Ka, currently program manager at an immuno oncology biotech in Singapore.
1. What N-of-1 and single-case projects are you working on right now?
I am not currently working on any N-of-1 projects.
2. What excites you most about the field of N-of-1 trials and single-case designs?
I am very intrigued by the potential of N-of-1 trials in furthering precision medicine, and in helping patients to find suitable treatments more efficiently.
3. Why did you join the ICN?
I am curious to know if there is a database of all N-of-1 studies conducted around the world, as a resource for patients/physicians looking for alternatives when standard of care treatments do not work.